Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci

Kainer, Marion A.; Devasia, Rose A.; Jones, Timothy F.; Simmons, Bryan P.; Melton, Kelley; Chow, Susan; Broyles, Joyce; Moore, Kelly L.; Craig, Allen S.; Schaffner, William

Back to Previous Page

Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci

Published Date:

Jul 2007

Source:

Emerg Infect Dis. 13(7):1024-1030.

[PDF-227.89 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Kainer, Marion A. ; Devasia, Rose A. ; Jones, Timothy F. ; Simmons, Bryan P. ; Melton, Kelley ; ... More ▼

Description:

Linezolid was approved in 2000 for treatment of gram-positive coccal infections. We performed a case-control study during a hospital outbreak of linezolid-resistant enterococci (LRE) infections, comparing cases of LRE infection (cases) with linezolid-sensitive enterococci infections (controls). Nasal and perirectal swab samples were obtained from all patients in a 1-day point-prevalence survey. We examined antimicrobial drug use and calculated the defined daily dose of linezolid per 1,000 patient-days. Fifteen LRE cases were identified (13 Enterococcus faecalis and 2 E. faecium); 7 were vancomycin-resistant. Compared with controls, case-patients had increased in-hospital mortality rates and lengths of stay. Multivariate analysis identified independent predictors of LRE infection: prior cultures positive for methicillin-resistant Staphylococcus aureus (adjusted odds ratio [AOR] 27), hospitalization duration before index culture (AOR 1.1 per day), and duration of preceding linezolid therapy (AOR 1.1 per day). Linezolid exposure and patient-to-patient transmission appear to be responsible for LRE infections, an important emeraina hospital problem.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

File Type:

Supporting Files:

	07-0019_appT-s1.pdf	application/pdf
	07-0019_finalR.nxml	text/plain
	license.txt	text/plain
	07-0019-F1.gif	image/gif
	07-0019-F1.jpg	image/jpeg
	07-0019-F2.gif	image/gif
	07-0019-F2.jpg	image/jpeg
	07-0019-F3.gif	image/gif
	07-0019-F3.jpg	image/jpeg
	07-0019-F4.gif	image/gif
	07-0019-F4.jpg	image/jpeg

No Related Documents.

Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future.

[PDF - 195.70 KB]

Personal Author:

Huycke, M. M. ; Sahm, D. F. ; ...

Published Date:

1998 Apr-Jun

Source:

Emerg Infect Dis. 4(2):239-249.

Description:

Enterococci, leading causes of nosocomial bacteremia, surgical wound infection, and urinary tract infection, are becoming resistant to many and someti...

File Type:

[PDF - 195.70 KB]

File Type:

[PDF - 195.70 KB]
Vancomycin-resistant Enterococci, Mexico City

[PDF - 194.51 KB]

Personal Author:

Cuellar-Rodríguez, Jennifer ; Galindo-Fraga, Arturo ; ...

Published Date:

May 2007

Source:

Emerg Infect Dis. 13(5):798-799.

File Type:

[PDF - 194.51 KB]

File Type:

[PDF - 194.51 KB]
De Novo Daptomycin-Nonsusceptible Enterococcal Infections

[PDF - 165.20 KB]

Personal Author:

Kelesidis, Theodoros ; Humphries, Romney ; ...

Published Date:

Apr 2012

Source:

Emerg Infect Dis. 18(4):674-676.

Description:

Potential emergence of enterococcal daptomycin nonsusceptibility among patients with no prior exposure to daptomycin poses clinical and public health ...

File Type:

[PDF - 165.20 KB]

File Type:

[PDF - 165.20 KB]
Emergence of vancomycin-resistant enterococci.

[PDF - 61.72 KB]

Personal Author:

Rice, L. B.

Published Date:

2001 Mar-Apr

Source:

Emerg Infect Dis. 7(2):183-187.

Description:

Vancomycin and ampicillin resistance in clinical Enterococcus faecium strains has developed in the past decade. Failure to adhere to strict infection ...

File Type:

[PDF - 61.72 KB]

File Type:

[PDF - 61.72 KB]
Linezolid- and Multidrug-Resistant Enterococci in Raw Commercial Dog Food, Europe, 2019–2020

[PDF - 978.70 KB]

Personal Author:

Freitas, Ana R. ; Finisterra, Liliana ; ...

Corporate Authors:

from the ESCMID Study Group on Food- and Water-borne Infections (EFWISG)

Published Date:

August 2021

Source:

Emerg Infect Dis. 27(8):2221-2224

Description:

We describe enterococci in raw-frozen dog food commercialized in Europe as a source of genes encoding resistance to the antibiotic drug linezolid and ...

File Type:

[PDF - 978.70 KB]

File Type:

[PDF - 978.70 KB]

Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci

Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC